Menü
Menü
The Digital Revolution in Pharma Manufacturing – A transformational journey through case studies
The pharma industry is undergoing a significant transformation due to the advent of digital technologies. Techniques such as visualization, modeling, automation, machine learning and artificial intelligence have the potential to dematerialize manufacturing processes and facilities, and drive productivity through fewer errors, higher output and improved quality, safety and speed of operations.
An upcoming ISPE D/A/CH event, to be held on 14-15 November 2018 in Basel, Switzerland, will feature:
– pharma case studies,
– learnings from other industries and
– discuss the regulatory framework of the digital transformation
in pharmaceutical manufacturing.
Organized by the ISPE DACH chapter and hosted by Novartis, this event showcases the digital transformation in pharma manufacturing through case studies. Participants will learn about digital technologies, their applicability to current operations, opportunities and challenges faced in the first years of digitalization. The event provides opportunities for benchmarking, networking and external engagement.
This event is tailored for mid-senior level management, decision makers, and leaders who set strategy and direction for manufacturing, quality and regulatory CMC in their organizations.
Agenda:
|
Wednesday, 14 November 2018 |
|
|
09:00 – 09:15 |
Opening remarks (Novartis) |
|
09:15 – 09:45 |
Keynote presentation (Novartis) The digital revolution – Visionary overview of possibilities, value to pharma |
|
09:45 – 10:30 |
Non-pharma Case Study (Tessella) Learning from the digital journey of other industries. Followed by Q&A. |
|
10:30 – 11:00 |
Coffee Break |
|
11:00 – 12:30 |
Pharma Case Studies: Novartis, Roche, Takeda, Bayer Learning from the digital journey of other companies. Followed by Q&A. |
|
12:30 – 14:00 |
Lunch Break |
|
14:00 – 15:30 |
Pharma Case Studies: BI, Biogen, Merck Serono, GSK Learning from the digital journey of other companies. Followed by Q&A. |
|
15:30 – 16:00 |
Coffee Break |
|
16:00 – 17:30 |
Pharma Case Studies: Novo Nordisk, J&J, Pfizer, Roche Learning from the digital journey of other companies. Followed by Q&A. |
|
17:30 – 19:30 |
Networking Reception |
|
Thursday, 15 November 2018 |
|
|
09:00 – 10:15 |
Big Data Issues (Novartis) Cybersecurity, Data Integrity. |
|
10:15 – 10:45 |
Coffee Break |
|
10:45 – 11:45 |
How can other stakeholders support the digital revolution? ISPE and PDA initiatives: Pharma 4.0, Big Data (ISPE, PDA) |
|
11:45 – 12:30 |
Panel discussion |
|
12:30 – 12:45 |
Closing remarks (Novartis) |
|
12:45 – 14:00 |
End of workshop, networking lunch |
Chair: Ursula Busse,
Head Quality Intelligence, External Engagement, Novartis
Co-Chair: Viktor Mettler,
Global Quality Lead REFS, NBS & Country Quality, Novartis
ISPE DACH Board representative
What?
The Digital Revolution in Pharma Manufacturing – A transformational journey through case studies
When?
14th to 15th of November, 2018
Where?
Novartis AG
Auditorium WSJ-510
Novartis Campus
Basel, Switzerland
Hotel recommendation
Swissotel Le Plaza Basel
Messeplatz 25
CH-4005 Basel
https://www.swissotel.de/hotels/basel/
Radisson Blu Basel
Steinentorstr. 25
CH-4001 Basel
https://www.radissonblu.com
Participation fee
ISPE Members: 450 Euros
Non Members: 650 Euros
Could we spark your interest?
.eveenoButton:link, .eveenoButton:visited, .eveenoButton:focus, .eveenoButton:hover, .eveenoButton:active {color: #fff; text-decoration: none;}
.eveenoButton {border-radius:3px; color: #fff; cursor: pointer; display: inline-block; font-family: arial,helvetica,sans-serif; font-weight: bold; font-size: 16px; padding: 4px 8px; text-align: center;}
.eveenoButton.orange {color: #fff !important; background-color: #fb9d23; border: 1px solid #000;}
.eveenoButton.orange:hover,.eveenoButton.orange:focus,.eveenoButton.orange:active {border:1px solid #cccccc; background-color:#e78404;}
Contact: ISPE D/A/CH Secretary Rolf Sopp (rolf.sopp(at)ispe-dach.org)